Accessibility Menu
National Graphite logo

National Graphite(OTC) NGRC

Market Cap$3.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-100%
5 Year-62%
1 Year-42%
1 Month-28%
$0.02
+0.00%
+0.00Today
National Graphite last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-04
National Graphite stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.022026-07-23
1 month-28.33%USD 0.032026-06-23
3 month-8.7%USD 0.022026-05-05
Year to date+0%USD 0.022025-12-31
1 year-41.67%USD 0.042025-08-04
3 year-55.32%USD 0.052023-08-01
5 year-62.23%USD 0.062021-08-05
Since inception-99.86%USD 15.002011-02-25

National Graphite Financials at a Glance

Market Cap

$3.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$1.24M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.41 (Low)

Price

$0.02

Volume

68

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.05

Estimated Earnings Date

N/A

NGRC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About National Graphite

National Graphite Corp. is a biopharmaceutical enterprise focused on innovative therapeutic platforms through strategic partnerships. Operating via its subsidiary, Biotech Development Corp., the company aims to address various health conditions, including rare disorders and unmet medical needs.

Products and Services
  • Development of novel biological entities
  • Partnerships with clinical-stage firms
  • Focus on postoperative inflammatory complications with ELAFIN
Growth Outlook
  • ELAFIN drug candidate shows promise in managing postoperative complications
  • Collaborative efforts with Proteo Inc. enhance development capabilities
  • Expanding pipeline targets a wide range of health conditions
Financial Highlights
  • Recent quarterly net income of $34,725 indicates potential for growth
  • Trailing twelve months (TTM) revenue of $0 reflects early-stage development
  • Current ratio of 0.022 suggests a focus on managing liabilities
National Graphite Corp. operates in a niche market with a commitment to advancing biopharmaceutical solutions. The company’s strategic partnerships and innovative product pipeline position it for potential growth in the healthcare sector. The recent quarterly net income, although modest, reflects the company's ability to generate positive cash flow amidst ongoing development efforts. The focus on ELAFIN and collaborations with established firms like Proteo Inc. may enhance its market presence and product offerings. Investors may find interest in the company's unique approach to addressing significant health challenges through innovative therapies.
AI Generated • Jul 31, 2026

Industry

Biotechnology

Sector

Health Care

CEO

John Chui

Website

www.nationalgraphitecorp.com

Headquarters

Las Vegas, NV 89149, US

NGRC Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

4.99%

Return on Capital

N/A

Return on Assets

-184.64%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

154.31M

Volume

68

Avg. Volume

1.09K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$1.44M

EBITDA

-$1.18M

Operating Cash Flow

-$2.29M

Capital Expenditure

$0.00

Free Cash Flow

-$2.29M

Cash & ST Invst.

$8.16K

Total Debt

$2.13M

National Graphite Performance Analysis

National Graphite annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
National Graphite sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12014-08-31N/A
Q22014-11-30N/A
Q32015-02-28N/A
Q42015-05-31N/A
National Graphite annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00N/A
20232023-12-31USD -0.00100.0%
20242024-12-31USD -0.00-25.0%
20252025-12-31USD -0.0033.3%
National Graphite sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12014-08-3132.8%
Q22014-11-30-2972.3%
Q32015-02-28-11.8%
Q42015-05-31100.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2014YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$3.24MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.24M

N/A

Employees

1

N/A

Net Income

$34.73K

-94.8%

EBITDA

$21.76K

-96.8%

Quarterly Fundamentals

Name
Q4 2014YOY CHG

Total Cash

$8.16K

+900.6%

Total Debt

$2.13M

+8716.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$820.39K

N/A

Short Term Debt

$1.31M

+5317.7%

Return on Assets

-1.85%

N/A

Return on Invested Capital

3.63%

N/A

Free Cash Flow

-$264.30K

-279.0%

Operating Cash Flow

-$264.30K

-279.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BDCMBroadcast Marketing Group, Inc.
$0.01+0.00%
ADHIArsenal Digital Holdings, Inc.
$0.17+0.00%
MVCOMetavesco, Inc.
$0.00-0.00%
ARATArax Holdings Corp.
$0.02-20.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$162.66+0.29%
SPCXSpace Exploration Technologies
$125.33+0.09%
NVDANvidia
$211.94+0.03%
INTCIntel
$100.86+0.11%

Questions About NGRC

What is the current price of National Graphite?

National Graphite is trading at $0.02 per share.

What is the 52-week range for National Graphite?

Over the past 52 weeks, National Graphite has traded between $0.02 and $0.05.

How much debt does National Graphite have?

As of the most recent reporting period, National Graphite reported total debt of $40.00K.

How much cash does National Graphite have on hand?

National Graphite reported $0.00 in cash and cash equivalents in its most recent financial results.

What is National Graphite’s dividend yield?

National Graphite does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services